ALSE — Alseres Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Alseres Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2009 December 31st	2010 December 31st	2011 December 31st	2012 December 31st	2013 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-10.8	0.512	-2.88	-1.65	-0.942
Depreciation
Non-Cash Items	2.19	-5.46	-0.496	0	0.546
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	0.455	1.93	0.852	0.692	-1.29
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-8.06	-2.95	-2.48	-0.952	-1.69
Capital Expenditures	0	0	-0.002	0	0
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.076	0.035	0.304	0	0.884
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.076	0.035	0.301	0	0.884
Financing Cash Flow Items	-0.025	0	0	0.325	0.175
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	8.22	2.7	2.22	0.833	0.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.241	-0.216	0.037	-0.119	0.097